Literature DB >> 9783262

Hemagglutinin binding mediated protection of botulinum neurotoxin from proteolysis.

S K Sharma1, B R Singh.   

Abstract

Type A Clostridium botulinum, the causative agent of the food poisoning botulism disease, secretes botulinum neurotoxins along with seven neurotoxin associated proteins (NAPs). The function of NAPs has been shown to protect the neurotoxin from acidity, heat, and proteolytic attack in the environmental and gastrointestinal tract during the toxicogenesis of the botulism disease. One of the NAPs, purified from type A botulinum neurotoxin complex, showed hemagglutination activity. A direct interaction has been demonstrated between purified NAP, a 33-kDa hemagglutinin or Hn-33, and the neurotoxin by using Sephadex G-200 column chromatography. Furthermore, Hn-33 has complete resistance against proteolytic attack at pH 2.0 as well as at normal physiological pH. We have investigated digestion of the neurotoxin in the presence and absence of Hn-33. The neurotoxin alone has been found to be more susceptible to the enzymatic digestion than neurotoxin with Hn-33. The presence of Hn-33 changes the proteolytic fragmentation pattern of the neurotoxin. It seems that Hn-33 protects the neurotoxin from proteolysis either by structural modification of the neurotoxin or by blocking the protease accessible sites of the neurotoxin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9783262

Source DB:  PubMed          Journal:  J Nat Toxins        ISSN: 1058-8108


  11 in total

1.  Molecular cloning of an apoptosis-inducing protein, pierisin, from cabbage butterfly: possible involvement of ADP-ribosylation in its activity.

Authors:  M Watanabe; T Kono; Y Matsushima-Hibiya; T Kanazawa; N Nishisaka; T Kishimoto; K Koyama; T Sugimura; K Wakabayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Structural biology. How a neurotoxin survives.

Authors:  Michael Adler
Journal:  Science       Date:  2012-02-24       Impact factor: 47.728

3.  Role of neurotoxin associated proteins in the low pH induced structural changes in the botulinum neurotoxin complex.

Authors:  Gowri Chellappan; Raj Kumar; Shuowei Cai; Bal Ram Singh
Journal:  Protein J       Date:  2014-12       Impact factor: 2.371

Review 4.  Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia.

Authors:  Wolfgang H Jost; Jörg Blümel; Susanne Grafe
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Molecular composition and extinction coefficient of native botulinum neurotoxin complex produced by Clostridium botulinum hall A strain.

Authors:  Anne-Marie Bryant; Jenny Davis; Shuowei Cai; Bal Ram Singh
Journal:  Protein J       Date:  2013-02       Impact factor: 2.371

6.  Thermostable llama single domain antibodies for detection of botulinum A neurotoxin complex.

Authors:  Ellen R Goldman; George P Anderson; Jerry Conway; Laura J Sherwood; Melissa Fech; BaoHan Vo; Jinny L Liu; Andrew Hayhurst
Journal:  Anal Chem       Date:  2008-10-24       Impact factor: 6.986

7.  Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.

Authors:  Shashi K Sharma; Joseph L Ferreira; Brian S Eblen; Richard C Whiting
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

8.  Cloning, expression, purification, and characterization of biologically active recombinant hemagglutinin-33, type A botulinum neurotoxin associated protein.

Authors:  Yu Zhou; Sowmya Paturi; Paul Lindo; Suzanne M Shoesmith; Bal Ram Singh
Journal:  Protein J       Date:  2007-01       Impact factor: 4.000

9.  A historical and proteomic analysis of botulinum neurotoxin type/G.

Authors:  Rebecca R Terilli; Hercules Moura; Adrian R Woolfitt; Jon Rees; David M Schieltz; John R Barr
Journal:  BMC Microbiol       Date:  2011-10-18       Impact factor: 3.605

Review 10.  Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review.

Authors:  Rami Burstein; Andrew M Blumenfeld; Stephen D Silberstein; Aubrey Manack Adams; Mitchell F Brin
Journal:  Headache       Date:  2020-06-30       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.